Carina Mari Aparici is currently working as a Clinical Professor in the Department of RADIOLOGY - Rad/Nuclear Medicine at Stanford University, USA.

Dr. Lucio Mango holds degree in Medicine at “La Sapienza“ University in Rome, Italy (1974). Is specialized in Nuclear Medicine (1977) and Endocrinology (1980) in the same University and is the Director of Nuclear Medicine Unit at the “S.Camillo-Forlanini” General Hospital in Rome (from 1999 up to now). He is also Scientific Director of the 2nd level Master(PhD) on Health Management at University of International Studies (UNINT), in Rome (from 20013 up to now). He is working on Nuclear Therapy research n Oncology and Endocrinology. Is Professor of Nuclear Medicine at “La Sapienza“ University (from 1997 up to now) in Rome and of Health Management at University of International Studies (UNINT) (from 2010 up to now), in Rome. He had published up to 180 papers in Nuclear Medicine, Oncology, Cardiology, Endocrinology, Health and Risk Management and Ethics, and He is also serves as an editorial member for various international journals.

Dr Sasaki is the director of the Clinical Research Centre of Shonan Kamakura General Hospital in Japan, which is affiliated with the Graduate School of Medicine, Yokohama City University, as well as serving as special adviser for the Oncology Centre of Hidaka Hospital. Dr Sasaki was trained as an internist and specialised in Nuclear Medicine at the University of Tokyo and Johns Hopkins Hospital. He has chaired departments of Radiology and Nuclear Medicine at several universities, including the University of Tokyo. He also served as director-general of the National Institute of Radiological Sciences. Dr Sasaki has served in ICRP, UNSCEAR and the Radiation Council of Japan. He received the Order of the Sacred Treasure, Gold and Silver Medal as well as other distinguished honours and awards. 

Mitchel Muhleman is currently working as an Assistant Professor in the Department of Radiology at UNC School of Medicine, USA.

Dr. Lin completed his Ph.D. degree in 2008 from Nanjing University. He then worked as a postdoc at Nanjing University (2008-2011) and visiting scholar at Stanford University School of Medicine (2013-2014). He was promoted an associate professor from 2012. He is now the director of research group at Jiangsu Institute of Nuclear Medicine. His main research interests are novel molecular imaging probes and anticancer drugs for tumors. He has published over 60 peer-reviewed papers.